CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,003 enrolled
Drug / intervention
Kidney Action Team Recommendationsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04040296
NCT04040296N/ACompleted
CompareCT.gov

Personalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized Trial

Yale University·interventional·Posted Jul 31, 2019·Updated Jul 17, 2025

In Brief

A clinical study evaluating Kidney Action Team Recommendations for Acute Kidney Injury. Completed, enrolled 4,003 participants across 1 site.

Detailed Summary

This is a randomized clinical trial of a "Kidney Action Team", which will provide timely, personalized recommendations for the diagnosis and initial treatment of hospitalized patients with Acute Kidney Injury (AKI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Injury
CountriesUnited States
CollaboratorsJohns Hopkins University

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 31, 2019
Enrollment StartOct 29, 2021
Primary CompletionFeb 22, 2024
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.9 years ago

Interventions

Kidney Action Team Recommendationsother

Upon review of the patient's medical information, the Kidney Action Team will create personalized recommendations that will be delivered to the patient's primary care team via a specialized note in the electronic medical record system within 2 hours of AKI detection. The attending of record will be identified as a cosigner to ensure that a member of the care team is made aware of the note's presence.